A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices

Clinics

Volumn 61, Issue 5, 2006, Pages 473-478

  Higuchi, Maria L ^a   Santos, Marilia H ^a   Roggério, Alessandra ^a   Kawakami, Joyce T ^a   Bezerra, Hiram G ^a   Canzian, Mauro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Archaea; Atherosclerosis; Chlamydia pneumoniae; Mycoplasma pneumoniae; Myxoid matrix

Indexed keywords

EID: 33750412639     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322006000500016     Document Type: Article

References (47)

1. van der Wal AC, Becker AE, van der Loos CM, Tigges AJ, Das PK. Fibrous and lipid-rich atherosclerotic plaques are part of interchangeable morphologies related to inflammation: a concept. Coron Artery Dis. 1994;5:463-9.
2. Steinberg D. Antioxidants and atherosclerosis. A current assessment. Circulation. 1991;84:1420-5.
3. Fuster V, Gotto AM, Libby P, Loscalzo J, McGill H. Task Force 1. Pathogenesis of coronary disease: The biologic role of risk factors. J Am Coll Cardiol. 1996;27:964-76.
4. Fuster V, Badimon J, Chesebro JH, Fallon JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis. 1996;26:269-84.
5. Steinberg D, Parhasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-24.
6. Simionescu M, Simionescu N. Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J. 1993;7:1359-66.
7. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Lipoprotein-proteoglycan complexes from atherosclerotic lesions promote cholesteryl ester accumulation in human monocytes/macrophages. Arterioscler Thromb. 1992;12:237-49.
8. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA. 1979;76:333-7.
9. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA. 1981;78:6499-503.
10. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-478.
11. Shor A, Phillips JI. Chlamydia pneumoniae and atherosclerosis. JAMA. 1999;282:2071-3.
12. Gupta S. Chronic infection in the aetiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis. 1999;143:1-6.
13. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 2006;113:929-37.
14. O'Connor S, Taylor C, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis. 2001;7:780-8.
15. Mahony JB, Coombes BK. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? FEMS Microbiol Lett. 2001;197:1-9.
16. Katz JT, Shannon RP. Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation. 2006;113:920-2.
17. Shah PK. Chronic infections and atherosclerosis/thrombosis. Curr Atheroscler Rep. 2002;4:113-9.
18. Higuchi ML, Sambiase N, Palomino S, Gutierrez P, Demarchi LM, Aiello VD, et al. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res. 2000; 33:1023-6.
19. Higuchi ML, Ramires JAF. Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Rev Inst Med Trop S.Paulo. 2002;44:217-24.
20. Santos MHH, Pierri H, Higuchi ML, Nussbacher A, Palomino S, Sambiase NV, et al. Chlamydia pneumonie e Mycoplasma pneumoniae nos nódulos de calcificação da estenose da valva aórtica. Arq Bras Cardiol. 2005;84:443-8.
21. Higuchi ML, Santos MHH, Pierri H, Palomino S, Sambiase NV, Ramires JAF, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in calcified nodules of aortic stenotic valves. Rev Inst Med Trop S.Paulo. 2002;44:209-12.
22. Nicolson GL, Gan R, Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes vírus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111:557-66.
23. Momiyama Y, Ohmori R, Taniguchi H, Nakamura H, Ohsuzu F. Association of Mycoplasma pneumoniae infection with coronary artery disease and its interaction with chlamydial infection. Atherosclerosis. 2004;176:139-44.
24. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidaion of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis. 1999;180:780-90.
25. Higuchi ML, Castelli JB, Aiello VD, Palomino S, Reis MM, Sambiase NV, et al. Great amount of C. pneumoniae in ruptured plaque vessel segments at autopsy. Arq Bras Cardiol. 2000;74:149-51.
26. Sies H. What is oxidative stress? In: Oxidative stress and vascular disease. Boston: Keaney JF Jr. Boston Kluwer Academic; 2000. p.1-8.
27. Imlay JA. Pathways of oxidative damage. Annu Rev Microbiol. 2003;57:395-418.
28. Cannio R, Florentino G, Morana A, Ossi M, Bartolucci S. Oxygen: friend or foe? Archaeal superoxide dismutases in the protection of intra- and extracellular oxidative stress. Front Biosci. 2000;5:D768-79.
29. Woese CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA. 1990;87:4576-9.
30. Lovley DR, Holmes DE, Nevin KP. Dissimilatory Fe(III) and Mn (IV) reduction. Adv Microb Physiol. 2004;49:219-86.
31. Kurtz DM Jr. Microbial detoxification of superoxide: the non-heme iron reductive paradigm for combating oxidative stress. Acc Chem Res. 2004;37:902-8.
32. Benvenuti LA, Onishi RY, Gutierrez PS, Higuchi ML. Different patterns of atherosclerotic remodeling in the thoracic and abdominal aorta. Clinics. 2005;60:355-60.
33. Higuchi ML, Sambiase NV, Gois JM, Ramires JAF. Aproximación a una nueva comprensión de la arteriosclerosis: Infecciones asociadas con Chlamydia y Mycoplasma y baja inmunidad. Rev Arg Cir Cardiovas. 2004;2:156-63.
34. Barns SM, Delwiche CF, Palmer JD, Pace NR. Perspectives on archaeal diversity, thermophily and monophyly from environmental rRNA sequences. Proc Natl Acad Sci USA. 1996;93:9188-93.
35. Eckburg PB, Lepp PW, Relman DA. Archaea and their potential role in human disease. Infect Immun. 2003;71:591-6.
36. Reeve JN. Archaebacteria then... Archaes now (are there really no archaeal pathogens?). J Bacteriol. 1999;181:3613-7.
37. Cavicchioli R, Curmi PM, Saunders N, Thomas T. Pathogenic archaea: do they exist? Bioessays. 2003;25:1119-28.
38. Florin TH, Zhu G, Kirk KM, Martin NG. Shared and unique environmental factors determine the ecology of methanogens in humans and rats. Am J Gastroenterol. 2000;95:2872-9.
39. Srinivasan V, Morowitz HJ. Ancient genes in contemporary persistent microbial pathogens. Biol Bull. 2006;210:1-9.
40. Vianna ME, Conrads G, Gomes BP, Horz HP. Identification and quantification of archaea involved in primary endodontic infections. J Clin Microbiol. 2006;44:1274-82.
41. Rachel R, Wyschkony I, Riehl S, Huber H. The ultrastructure of Ignicoccus: evidence for a novel outer membrane and for intracellular vesicle budding in an archaeon. Archaea. 2002;1:9-18.
42. Peretó J, López-Garcia P, Moreira D. Ancestral lipid biosynthesis and early membrane evolution. Trends Biochem Sci. 2004;29:469-77.
43. Howland JL. Archaeal portraits. In: The surprising archaea. Discovering another domain of life. New York: Oxford University press; 2000. p.79.
44. Ring G, Eichler J. Characterization of inverted membrane vesicles from the halophilic archaeon Haloferax volcanii. J Membr Biol. 2001;183:195-204.
45. Simonen-Jokinen TL, Eskelinen UM, Hartel HM, Nikunen SK, Saloniemi HS, Maisi PS. Gelatinolytic matrix metalloproteinases-2 and -9 in tracheobronchial lavage fluid obtained from calves with concurrent infections of Pasteurella multocida and Mycoplasma bovirhinis. Am J Vet Res. 2005;66:2101-6.
46. Dias-Perales A, Quesada V, Peinado JR, Ugalde AP, Alvarez MF, Gomis-Rüth FX, et al. Identification and characterization of human archaemetzincin-1 and-2, towo novel members of a family of metalloproteases widely distributed in archaea. J Biol Chem. 2005;280:30367-75.
47. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA Jr, Willerson JT, et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation. 1998;98(19 Suppl):II331-7.